Cardiovascular effects of the combination of OPC-18790 and dopamine in halothane-anesthetized dogs.

Abstract

OPC-18790, (+/-)-6-[3-(3,4-dimethoxybenzylamino)-2-hydroxypropoxy]-2(1H)-quin olinone, is a novel positive inotropic agent, and its mechanism of positive inotropic action involves not only phosphodiesterase inhibition, but also a prolongation of action potential duration in ventricular muscle. Prolongation of action potential duration is also a property of class III antiarrhythmic agents; therefore, we examined the cardiohemodynamic effects and arrhythmogenicity of a combination of OPC-18790 and dopamine in halothane-anesthetized dogs. Dopamine (5 micrograms/kg/min) alone increased the peak of the first derivative of left ventricular pressure (LVdP/dtmax) and cardiac output (CO) by 43-48% and 16-20%, respectively, while OPC-18790 (10 micrograms/kg/min) increased these parameters by 56% and 22%, respectively. The combination of OPC-18790 (10 micrograms/kg/min) and dopamine (5 micrograms/kg/min) and dopamine alone at an increased dose of 10 micrograms/kg/min further increased LVdP/dtmax and CO by 104-113% and 29-30%, respectively. Thus, positive inotropic effects were equally observed in both groups, and the effects of OPC-18790 and dopamine seemed to be additive. The other hemodynamic effects were similar among all groups. Arrhythmias such as premature ventricular contraction developed in 5 out of 7 dogs (71.4%) in the 10-micrograms/kg/min dopamine group, while only one premature ventricular contraction was observed in 1 of 7 dogs (14.3%) in the OPC-18790 (10 micrograms/kg/min) and dopamine (5 micrograms/kg/min) combination group. These results suggest that the combination of OPC-18790 and dopamine may provide new therapeutic options for the treatment of heart failure.

• Authors: S Itoh, T Mori, K Yoshida, H Fujiki, M Tominaga, Y Yabuuchi
• Journal: Japanese journal of pharmacology (Jpn J Pharmacol) Vol. 69 Issue 3 Pg. 229-37 (Nov 1995) ISSN: 0021-5198 [Print] Japan
• PMID: 8699631 (Publication Type: Journal Article)

Chemical References

• Cardiotonic Agents
• Drug Combinations
• Quinolones
• toborinone
• Halothane
• Dopamine

Topics

• Animals
• Blood Pressure (drug effects)
• Cardiotonic Agents (pharmacology)
• Dogs
• Dopamine (pharmacology)
• Drug Combinations
• Female
• Halothane (pharmacology)
• Heart Rate (drug effects)
• Male
• Quinolones (pharmacology)
• Time Factors